ClinicalTrials.gg
Status unknownNCT03249701EASUpdated Apr 2, 2018

Electrical Acupoint Stimulation for Postoperative Recovery

An interventional study of Transcutaneous Electrical Acupoint Stimulation and Electroacupuncture in Postoperative Complications, Postoperative Nausea and Vomiting and Postoperative Infection, sponsored by Shandong University of Traditional Chinese Medicine. Status unknown at 1 site in China. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-04-02.

Sponsored by Shandong University of Traditional Chinese Medicine · Not applicable, Interventional, and Prevention

How we know

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 159 studies in Postoperative Complications with a site in China — 47 open to participants now, 54 under way, none of them phase 3. Postoperative Complications · China.

Planned enrollment
76th of 96
90 · median 205
Started
2018
with 12 others
No phase
72 of 159
28 open now
Registered
36th of 159
by date

Among the 159 studies in Postoperative Complications with a site in China, this one is the 76th largest by planned enrollment of the 96 interventional ones that give a count, is one of 13 that started in 2018, is one of 72 with no phase, and was the 36th registered.

Postoperative Complications

1,342 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

47 of the 159 studies in Postoperative Complications with a site in China are open now. Recruiting first, the newest first:

42 more — sign in →

All 47 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 65 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 159 studies in Postoperative Complications with a site in China, or all of them as a file.
02

Study summary

This study investigates electrical acupoint stimulation (EAS) administered in peri-operation for improving postoperative recovery in elder patients, who accept knee arthroplasty. the surgery cause to change of stress response, which might be associated with postoperative recovery of patient Totally, three groups are created, 1/3 participants receive transcutaneous electrical acupoint stimulation, 1/3 participants receive electroacupuncture, the rest 1/3 will use sham transcutaneous electrical acupoint stimulation.

Read the detailed description

Theoretically, the application of electrical acupoint stimulation (EAS) base on the theory of traditional Chinese medicine. It deems that a surgery might consume Qi, then cause to imbalance of Qi and Blood, especially in elder patients. Besides, surgery lead to change of stress response (hormones). The EAS administration intra-operatively perhaps be beneficial to recovery of patients, reduce the incidence of postoperative complications. The main possible mechanism was stress response regulation. The hypothesis is that the EAS improve postoperative recovery of patient through regulating stress response.

03

Conditions studied

  • Postoperative Complications
  • Postoperative Nausea and Vomiting
  • Postoperative Infection
  • Postoperative Delirium
  • Postoperative Pneumonia
  • Deep Vein Thrombosis
  • Postoperative Retention of Urine
  • Postoperative Recovery

Keywords

  • Acupoint Stimulation
  • postoperative recovery
  • Postoperative Complications
  • Peri-operation
04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Agree to sign the contract
  • The patients receive total hip or knee arthroplasty
  • Epidural anesthesia administered

Exclusion criteria

Exclusion Criteria:

  • The patients' age out of range setting
  • Forbidden to the administration of transcutaneous electrical acupoint stimulation
  • Communication disorder
  • The patients who had medical history of cerebral vascular diseases, deep vein thrombosis, urinary retention, nausea and vomiting.
  • The patients who attended another trial in the past three months
  • Emergency surgery
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    TEAS group

    Transcutaneous Electrical Acupoint Stimulation on Neiguan, Quchi, Zusanli, Sanyinjiao. Intensity: maximal tolerance by subject; Time span: 30minutes before anesthesia induction and 30 minutes after wound closure.

    Device: Transcutaneous Electrical Acupoint Stimulation

  • Placebo comparator
    Electroacupuncture group

    Hand-needle on Neiguan, Quchi, Zusanli, Sanyinjiao.Intensity: maximal tolerance by subject; Time span: 30minutes before anesthesia induction and 30 minutes after wound closure.

    Device: Electroacupuncture

  • Sham comparator
    sham TEAS group

    Sham transcutaneous electrical acupoint stimulation on Neiguan, Quchi, Zusanli, Sanyinjiao; Intensity: maximal tolerance by subject; Time span: 30minutes before anesthesia induction and 30 minutes after wound closure.

    Device: sham Transcutaneous Electrical Acupoint Stimulation

Interventions

  • DeviceTranscutaneous Electrical Acupoint Stimulation

    The intervention will be administered by electrical acupoint machine, the brand is Great Wall.

  • DeviceElectroacupuncture

    The intervention will be administered by electrical acupoint machine, the brand is Great Wall.

  • Devicesham Transcutaneous Electrical Acupoint Stimulation

    The intervention will be administered by transcutaneous electrical acupoint machine, even no truly actualized.

06

What researchers measure

Primary outcomes

  1. The postoperative recovery

    Record the postoperative recovery after surgery through quality of recovery-40 questionnaire.

    Time frame: 7 days

Secondary outcomes

  1. The adverse event

    Record all the adverse events appeared during the entire trail, which might cause to skin rash, allergic reaction, et al.

    Time frame: 7 days

  2. The level of stress response

    Assess the level of preoperative stress response at 1, 3, 7 days after operation. It mainly include Adrenocorticotropic Hormone (ACTH), Cortisol (COR), Adrenaline (E), norepinephrine (NE). All measures unit is pg/ml.

    Time frame: up to 7 days

  3. Postoperative complications

    Record the incidence of any postoperative complications during 7 days

    Time frame: 7 days

  4. The level of inflammatory response by TNF-a, IL-1, IL-6, IL-10

    Assess the level of perioperative inflammatory response at 1, 3, 7 days after operation. It mainly include Tumor Necrosis Factor-a (TNF-a), Interleukins-1 (IL-1), Interleukins-6 (IL-6), Interleukins-10 (IL-10). All measures unit is ng/ml.

    Time frame: up to 7 days

  5. The level of inflammatory response by C-reactive protein

    Assess the level of perioperative inflammatory response at 1, 3, 7 days after operation through C-reactive protein. the unit is mg/L.

    Time frame: up to 7 days

Other outcomes

  1. Age in years

    Once patients enrolled, the age (years) need to be recorded ahead of operation.

    Time frame: 1 day

  2. ASA classification status

    Once patients enrolled, the ASA condition need to be recorded ahead of operation depend on the ASA classification.

    Time frame: 1 day

  3. Gender

    Once patients enrolled, the gender need to be recorded ahead of operation.

    Time frame: 1 day

  4. Weight in kilograms

    Once patients enrolled, the weight (kilograms) need to be recorded ahead of operation.

    Time frame: 1 day

  5. Height in meters

    Once patients enrolled, the height (meters) need to be recorded ahead of operation.

    Time frame: 1 day

  6. BMI in kg/m^2

    Once patients enrolled, the BMI (weight and height will be combined to report BMI in kg/m\^2) will be reported base on weight and height ahead of operation.

    Time frame: 1 day

07

Study locations

1 site
  • Affiliated hospital of shandong university of traditional chinese medicine
    Ji'nan, Shandong 250011, China
08

References and documents

Publications

  • Coburn M, Fahlenkamp A, Zoremba N, Schaelte G. Postoperative cognitive dysfunction: Incidence and prophylaxis. Anaesthesist. 2010 Feb;59(2):177-84; quiz 185. doi: 10.1007/s00101-009-1657-2. PubMed 20084351 ↗
  • Choi JB, Shim YH, Lee YW, Lee JS, Choi JR, Chang CH. Incidence and risk factors of postoperative nausea and vomiting in patients with fentanyl-based intravenous patient-controlled analgesia and single antiemetic prophylaxis. Yonsei Med J. 2014 Sep;55(5):1430-5. doi: 10.3349/ymj.2014.55.5.1430. PubMed 25048507 ↗
  • Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville (MD): Office of the Surgeon General (US); 2008. Available from http://www.ncbi.nlm.nih.gov/books/NBK44178/ PubMed 20669525 ↗
  • Montazeri AS, Hamidzadeh A, Raei M, Mohammadiun M, Montazeri AS, Mirshahi R, Rohani H. Evaluation of Oral Ginger Efficacy against Postoperative Nausea and Vomiting: A Randomized, Double - Blinded Clinical Trial. Iran Red Crescent Med J. 2013 Dec;15(12):e12268. doi: 10.5812/ircmj.12268. Epub 2013 Dec 5. PubMed 24693389 ↗
  • Sorrell JM. Postoperative cognitive dysfunction in older adults: a call for nursing involvement. J Psychosoc Nurs Ment Health Serv. 2014 Nov;52(11):17-20. doi: 10.3928/02793695-20141021-03. PubMed 25375388 ↗
  • Ge Y, Ma Z, Shi H, Zhao Y, Gu X, Wei H. [Incidence and risk factors of postoperative cognitive dysfunction in patients underwent coronary artery bypass grafting surgery]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Oct;39(10):1049-55. doi: 10.11817/j.issn.1672-7347.2014.10.011. Chinese. PubMed 25355258 ↗
  • Tsay SL, Cho YC, Chen ML. Acupressure and Transcutaneous Electrical Acupoint Stimulation in improving fatigue, sleep quality and depression in hemodialysis patients. Am J Chin Med. 2004;32(3):407-16. doi: 10.1142/S0192415X04002065. PubMed 15344424 ↗
  • Kabalak AA, Akcay M, Akcay F, Gogus N. Transcutaneous electrical acupoint stimulation versus ondansetron in the prevention of postoperative vomiting following pediatric tonsillectomy. J Altern Complement Med. 2005 Jun;11(3):407-13. doi: 10.1089/acm.2005.11.407. PubMed 15992223 ↗
  • Yao Y, Zhao Q, Gong C, Wu Y, Chen Y, Qiu L, Wu X, Chen Y. Transcutaneous Electrical Acupoint Stimulation Improves the Postoperative Quality of Recovery and Analgesia after Gynecological Laparoscopic Surgery: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2015;2015:324360. doi: 10.1155/2015/324360. Epub 2015 Jun 11. PubMed 26170873 ↗
  • Zheng LH, Sun H, Wang GN, Liang J, Wu HX. Effect of transcutaneous electrical acupoint stimulation on nausea and vomiting induced by patient controlled intravenous analgesia with tramadol. Chin J Integr Med. 2008 Mar;14(1):61-4. doi: 10.1007/s11655-007-9006-2. PubMed 18219451 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — IPD sharing content included the intervention protocol, record or data collected for the primary and secondary outcome measures.

Supporting information: Study protocol, Informed consent form, Clinical study report, Analytic code

Time frame: Data will be available within 6 months of study completion, forever.

Access criteria: Anyone are available to access the data collected on this website with requiring to sign the Data Access Agreement.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2018; primary completion for May 2019, 12 months later.

Of 395 non-industry interventional studies with no phase under Postoperative Complications, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 12 months is below that.

Counting every sponsor, half of 399 studies reached it within 20 months; a quarter within 8 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2017
First posted
Aug 15, 2017
StartEst.
May 1, 2018
Primary completionEst.
May 1, 2019
CompletionEst.
Oct 30, 2019
Last update
Apr 2, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03249701
Lead sponsor
Shandong University of Traditional Chinese Medicine
Responsible party
weiliang zhang (Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine) — Principal investigator
First posted
Aug 15, 2017
Start date
May 1, 2018 (estimated)
Primary completion
May 1, 2019 (estimated)
Completion
Oct 30, 2019 (estimated)
Last update
Apr 2, 2018

Study contacts

zhang weiliang, MD
Contact
hezhangweiliang@163.com
086-0531-68617021 ext. 6114
Su Fan, MD
Contact
boatsail@163.com
086-0531-68617023 ext. 6114
Su Fan, MD
principal investigator · Shandong University of Traditional Chinese Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion